Targeting NAD + Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma

Antibodies targeting CD38, a NAD -degrading enzyme, have emerged as a promising immunotherapy against multiple myeloma (MM). Currently, the mechanisms by which anti-CD38 antibodies establish their therapeutic effects are poorly understood. Here, we advocate for the depletion of NAD to enhance the ef...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Trends in Cancer 2020-01, Vol.6 (1), p.9-12
Hauptverfasser:	Kennedy, Barry E, Sadek, Maryanne, Elnenaei, Manal O, Reiman, Anthony, Gujar, Shashi A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!